Rothblatt Martine A's Form 4 filing
United Therapeutics Corp (UTHR) · filed Aug 27, 2026
- Accession no.
- 0001106578-26-000129
- Filed
- Aug 27, 2026, 4:34 PM ET
- Trade date
- Aug 26, 2026
- Filing delay
- 1 day
- Rule 10b5-1 plan
- Checked
This filing lists 9 non-derivative transactions and 1 derivative transaction. Open-market sales total $4.91M. It was filed 1 day after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Rothblatt Martine ACIK 0001106578 | Director, Officer (Chairperson & CEO) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Aug 26, 2026 | Common Stock | MOption exerciseAcquired | +9,500 | $135.42 | +$1,286,490 | 333,943 | Indirect | |
| Aug 26, 2026 | Common Stock | SSaleDisposed | −559 | $514.64F3 | −$287,682.42 | 333,384 | Indirect | |
| Aug 26, 2026 | Common Stock | SSaleDisposed | −1,591 | $515.41F4 | −$820,009.51 | 331,793 | Indirect | |
| Aug 26, 2026 | Common Stock | SSaleDisposed | −1,128 | $516.70F5 | −$582,832.07 | 330,665 | Indirect | |
| Aug 26, 2026 | Common Stock | SSaleDisposed | −3,516 | $517.49F6 | −$1,819,502.93 | 327,149 | Indirect | |
| Aug 26, 2026 | Common Stock | SSaleDisposed | −1,790 | $518.35F7 | −$927,846.14 | 325,359 | Indirect | |
| Aug 26, 2026 | Common Stock | SSaleDisposed | −476 | $519.35F8 | −$247,210.7 | 324,883 | Indirect | |
| Aug 26, 2026 | Common Stock | SSaleDisposed | −400 | $520.62F9 | −$208,246.76 | 324,483 | Indirect | |
| Aug 26, 2026 | Common Stock | SSaleDisposed | −40 | $521.48F10 | −$20,859.08 | 324,443 | Indirect |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Aug 26, 2026 | Common Stock | MOption exerciseDisposed | −9,500 | $0.00 | $0 | 56,410 | Indirect |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F3
This transaction was executed in multiple trades at prices ranging from $514.03 to $515.00. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
Referenced by the price of 1 transaction in Table I.
- F4
This transaction was executed in multiple trades at prices ranging from $515.05 to $516.00. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
Referenced by the price of 1 transaction in Table I.
- F5
This transaction was executed in multiple trades at prices ranging from $516.05 to $517.04. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder ofthe issuer full information regarding the number of shares and prices at which the transaction was effected.
Referenced by the price of 1 transaction in Table I.
- F6
This transaction was executed in multiple trades at prices ranging from $517.05 to $518.03. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
Referenced by the price of 1 transaction in Table I.
- F7
This transaction was executed in multiple trades at prices ranging from $518.05 to $519.02. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
Referenced by the price of 1 transaction in Table I.
- F8
This transaction was executed in multiple trades at prices ranging from $519.05 to $519.97. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
Referenced by the price of 1 transaction in Table I.
- F9
This transaction was executed in multiple trades at prices ranging from $520.35 to $521.26. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
Referenced by the price of 1 transaction in Table I.
- F10
This transaction was executed in multiple trades at prices ranging from $521.44 to $521.55. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
Referenced by the price of 1 transaction in Table I.